Is AMGN stock overvalued right now?

Based on our discounted cash flow and relative valuation models, AMGN appears to trade above fair value by approximately 48.7%. This suggests the market may be pricing in elevated growth expectations or sentiment premiums.

What is AMGN fair value based on current fundamentals?

Our fair value estimate for AMGN is $192.71, derived from discounted cash flow, dividend discount, and relative valuation multiples. The estimate assumes a discount rate of 9.0% and terminal growth of 2.5%.

How risky is AMGN compared with other stocks?

AMGN carries a beta of 0.43 suggests a defensive profile. Investors should weigh macro exposure against their own risk tolerance.

Is AMGN still growing?

Latest trailing metrics show revenue growth of 9.5% and earnings growth of 64.9%. Profit margins are 23.0%.

What do analysts think about AMGN?

Analyst consensus target is $388.03, implying 3.3% upside. The street recommendation is "hold".

Does AMGN pay a dividend?

Yes. AMGN currently offers a dividend yield of 2.6%.

What could change the investment case for AMGN?

Key catalysts include Healthcare sector dynamics, interest rate shifts, and company-specific earnings surprises. Monitor macro risk scores and analyst estimate revisions for early signals.

HealthcareUpdated·Data: Yahoo Finance, SEC EDGAR·Data delayed ~5 min

Review AMGN High Conviction Pick Working Capital result Run

NMS · Healthcare · Drug Manufacturers - General

$375.65

-5.85 (-1.53%)

Stock valuation guide Macro risk explained guide

About the Author

Phasakorn Traklang (Peach) — Founder

Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.

Connect on LinkedIn

Investment Disclaimer: QuantSoar is for informational purposes only. We do not provide personalized investment advice. Always conduct your own research or consult a financial advisor. SEC

Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.